Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining chemotherapy with autologous peripheral stem cell
transplantation and immunotherapy may allow the doctor to give higher doses of chemotherapy
drugs and kill more cancer cells. Biological therapies use different ways to stimulate the
immune system and stop cancer cells from growing.
PURPOSE: Randomized phase I/II trial to study the effectiveness of combining chemotherapy
with peripheral stem cell transplantation followed by immunotherapy in treating patients who
have multiple myeloma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore